Global COVID-19 In-Vitro Diagnostics Market Size, Status and Forecast 2020-2026

June 2020 | 132 pages | ID: G59C71A0EEB2EN
QYResearch

Abstracts

This report focuses on the global COVID-19 In-Vitro Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 In-Vitro Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Cellex
• Abbott
• Roche
• BioMedomics
• BD
• Henry Schein
• Safecare Bio-Tech
• Mayo Clinic Laboratories
• Chembio Diagnostics
• Mount Sinai Laboratory
• Ortho Clinical Diagnostics
• Zhejiang Orient Gene Biotech
• Innovita Biological Technology
• Guangzhou Wondfo Biotech
• Guangdong Hecin-Scientific
• Dynamiker Biotechnology (Tianjin)
• ADVAITE

Market segment by Type, the product can be split into

• Rapid Diagnostic Test (RDT)
• Enzyme Linked Immunosorbent Assay (ELISA)
• Neutralization Assay

Market segment by Application, split into

• Home
• Hospital
• Clinical

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global COVID-19 In-Vitro Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the COVID-19 In-Vitro Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 In-Vitro Diagnostics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 In-Vitro Diagnostics Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rapid Diagnostic Test (RDT)
  1.4.3 Enzyme Linked Immunosorbent Assay (ELISA)
  1.4.4 Neutralization Assay
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global COVID-19 In-Vitro Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Home
  1.5.3 Hospital
  1.5.4 Clinical
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 In-Vitro Diagnostics Industry Impact
  1.6.1 How the Covid-19 is Affecting the COVID-19 In-Vitro Diagnostics Industry
    1.6.1.1 COVID-19 In-Vitro Diagnostics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and COVID-19 In-Vitro Diagnostics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for COVID-19 In-Vitro Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Covid-19 Implications on Global COVID-19 In-Vitro Diagnostics Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global COVID-19 In-Vitro Diagnostics Growth Trends by Regions
  2.2.1 COVID-19 In-Vitro Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 COVID-19 In-Vitro Diagnostics Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 COVID-19 In-Vitro Diagnostics Revenue by Players (2019-2020)
3.2 COVID-19 In-Vitro Diagnostics Key Players Head office and Area Served
3.3 Key Players COVID-19 In-Vitro Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 In-Vitro Diagnostics Market
3.5 Key Players COVID-19 In-Vitro Diagnostics Funding/Investment Analysis
3.6 Global Key Players COVID-19 In-Vitro Diagnostics Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 GLOBAL COVID-19 IN-VITRO DIAGNOSTICS MARKET SIZE BY TYPE (2019-2026)

5 GLOBAL COVID-19 IN-VITRO DIAGNOSTICS MARKET SIZE BY APPLICATION (2019-2026)

6 NORTH AMERICA

6.1 North America COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
6.2 COVID-19 In-Vitro Diagnostics Key Players in North America (2019-2020)
6.3 North America COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
6.4 North America COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
7.2 COVID-19 In-Vitro Diagnostics Key Players in Europe (2019-2020)
7.3 Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
7.4 Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
8.2 COVID-19 In-Vitro Diagnostics Key Players in China (2019-2020)
8.3 China COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
8.4 China COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
9.2 COVID-19 In-Vitro Diagnostics Key Players in Japan (2019-2020)
9.3 Japan COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
9.4 Japan COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
10.2 COVID-19 In-Vitro Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
11.2 COVID-19 In-Vitro Diagnostics Key Players in India (2019-2020)
11.3 India COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
11.4 India COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America COVID-19 In-Vitro Diagnostics Market Forecast (2019-2026)
12.2 COVID-19 In-Vitro Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 In-Vitro Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 In-Vitro Diagnostics Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Cellex
  13.1.1 Cellex Company Details
  13.1.2 Cellex Business Overview and Its Total Revenue
  13.1.3 Cellex COVID-19 In-Vitro Diagnostics Introduction
  13.1.4 Cellex Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.1.5 Cellex Recent Development
13.2 Abbott
  13.2.1 Abbott Company Details
  13.2.2 Abbott Business Overview and Its Total Revenue
  13.2.3 Abbott COVID-19 In-Vitro Diagnostics Introduction
  13.2.4 Abbott Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.2.5 Abbott Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche COVID-19 In-Vitro Diagnostics Introduction
  13.3.4 Roche Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.3.5 Roche Recent Development
13.4 BioMedomics
  13.4.1 BioMedomics Company Details
  13.4.2 BioMedomics Business Overview and Its Total Revenue
  13.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Introduction
  13.4.4 BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.4.5 BioMedomics Recent Development
13.5 BD
  13.5.1 BD Company Details
  13.5.2 BD Business Overview and Its Total Revenue
  13.5.3 BD COVID-19 In-Vitro Diagnostics Introduction
  13.5.4 BD Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.5.5 BD Recent Development
13.6 Henry Schein
  13.6.1 Henry Schein Company Details
  13.6.2 Henry Schein Business Overview and Its Total Revenue
  13.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Introduction
  13.6.4 Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.6.5 Henry Schein Recent Development
13.7 Safecare Bio-Tech
  13.7.1 Safecare Bio-Tech Company Details
  13.7.2 Safecare Bio-Tech Business Overview and Its Total Revenue
  13.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Introduction
  13.7.4 Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.7.5 Safecare Bio-Tech Recent Development
13.8 Mayo Clinic Laboratories
  13.8.1 Mayo Clinic Laboratories Company Details
  13.8.2 Mayo Clinic Laboratories Business Overview and Its Total Revenue
  13.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Introduction
  13.8.4 Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.8.5 Mayo Clinic Laboratories Recent Development
13.9 Chembio Diagnostics
  13.9.1 Chembio Diagnostics Company Details
  13.9.2 Chembio Diagnostics Business Overview and Its Total Revenue
  13.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Introduction
  13.9.4 Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.9.5 Chembio Diagnostics Recent Development
13.10 Mount Sinai Laboratory
  13.10.1 Mount Sinai Laboratory Company Details
  13.10.2 Mount Sinai Laboratory Business Overview and Its Total Revenue
  13.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Introduction
  13.10.4 Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  13.10.5 Mount Sinai Laboratory Recent Development
13.11 Ortho Clinical Diagnostics
  10.11.1 Ortho Clinical Diagnostics Company Details
  10.11.2 Ortho Clinical Diagnostics Business Overview and Its Total Revenue
  10.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Introduction
  10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.11.5 Ortho Clinical Diagnostics Recent Development
13.12 Zhejiang Orient Gene Biotech
  10.12.1 Zhejiang Orient Gene Biotech Company Details
  10.12.2 Zhejiang Orient Gene Biotech Business Overview and Its Total Revenue
  10.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Introduction
  10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.12.5 Zhejiang Orient Gene Biotech Recent Development
13.13 Innovita Biological Technology
  10.13.1 Innovita Biological Technology Company Details
  10.13.2 Innovita Biological Technology Business Overview and Its Total Revenue
  10.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Introduction
  10.13.4 Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.13.5 Innovita Biological Technology Recent Development
13.14 Guangzhou Wondfo Biotech
  10.14.1 Guangzhou Wondfo Biotech Company Details
  10.14.2 Guangzhou Wondfo Biotech Business Overview and Its Total Revenue
  10.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Introduction
  10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.14.5 Guangzhou Wondfo Biotech Recent Development
13.15 Guangdong Hecin-Scientific
  10.15.1 Guangdong Hecin-Scientific Company Details
  10.15.2 Guangdong Hecin-Scientific Business Overview and Its Total Revenue
  10.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Introduction
  10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.15.5 Guangdong Hecin-Scientific Recent Development
13.16 Dynamiker Biotechnology (Tianjin)
  10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
  10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview and Its Total Revenue
  10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Introduction
  10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
13.17 ADVAITE
  10.17.1 ADVAITE Company Details
  10.17.2 ADVAITE Business Overview and Its Total Revenue
  10.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Introduction
  10.17.4 ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business (2019-2020))
  10.17.5 ADVAITE Recent Development

14 MARKET DYNAMICS

14.1 Drivers
14.2 Challenges
14.3 Porter’s Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 KEY FINDINGS IN THIS REPORT

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. COVID-19 In-Vitro Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 In-Vitro Diagnostics Revenue
Table 3. Ranking of Global Top COVID-19 In-Vitro Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rapid Diagnostic Test (RDT)
Table 6. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 7. Key Players of Neutralization Assay
Table 8. COVID-19 Impact Global Market: (Four COVID-19 In-Vitro Diagnostics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for COVID-19 In-Vitro Diagnostics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for COVID-19 In-Vitro Diagnostics Players to Combat Covid-19 Impact
Table 13. Global COVID-19 In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 In-Vitro Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 In-Vitro Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global COVID-19 In-Vitro Diagnostics Market Share by Regions 2019-2026
Table 17. Market Top Trends
Table 18. Market Use Cases
Table 19. Global COVID-19 In-Vitro Diagnostics Revenue by Players (2019-2020) (Million US$)
Table 20. Global COVID-19 In-Vitro Diagnostics Market Share by Players (2019-2020)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players COVID-19 In-Vitro Diagnostics Product Solution and Service
Table 23. Date of Enter into COVID-19 In-Vitro Diagnostics Market
Table 24. Global Key Players COVID-19 In-Vitro Diagnostics Funding/Investment Analysis (Million USD)
Table 25. Global Key Players COVID-19 In-Vitro Diagnostics Valuation & Market Capitalization (Million USD)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 28. Global COVID-19 In-Vitro Diagnostics Market Size Share by Type (2019-2026)
Table 29. Global COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 30. Global COVID-19 In-Vitro Diagnostics Market Size Share by Application (2019-2026)
Table 31. North America Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 32. North America Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 33. North America COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 34. North America COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 35. North America COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 36. North America COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 37. Europe Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 38. Europe Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 39. Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 40. Europe COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 41. Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 42. Europe COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 43. China Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 44. China Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 45. China COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 46. China COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 47. China COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 48. China COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 49. Japan Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 50. Japan Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 51. Japan COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 52. Japan COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 53. Japan COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 54. Japan COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 55. Southeast Asia Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 56. Southeast Asia Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 57. Southeast Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 58. Southeast Asia COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 59. Southeast Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 60. Southeast Asia COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 61. India Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 62. India Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 63. India COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 64. India COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 65. India COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 66. India COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 67. Central & South America Key Players COVID-19 In-Vitro Diagnostics Revenue (2019-2020) (Million US$)
Table 68. Central & South America Key Players COVID-19 In-Vitro Diagnostics Market Share (2019-2020)
Table 69. Central & South America COVID-19 In-Vitro Diagnostics Market Size by Type (2019-2026) (Million US$)
Table 70. Central & South America COVID-19 In-Vitro Diagnostics Market Share by Type (2019-2026)
Table 71. Central & South America COVID-19 In-Vitro Diagnostics Market Size by Application (2019-2026) (Million US$)
Table 72. Central & South America COVID-19 In-Vitro Diagnostics Market Share by Application (2019-2026)
Table 73. Cellex Company Details
Table 74. Cellex Business Overview
Table 75. Cellex Product
Table 76. Company Description and Business Overview
Table 77. Cellex COVID-19 In-Vitro Diagnostics Product
Table 78. Cellex Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 79. Cellex Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Company Description and Business Overview
Table 84. Abbott COVID-19 In-Vitro Diagnostics Product
Table 85. Abbott Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 86. Abbott Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Product
Table 90. Company Description and Business Overview
Table 91. Roche COVID-19 In-Vitro Diagnostics Product
Table 92. Roche Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 93. Roche Recent Development
Table 94. BioMedomics Company Details
Table 95. BioMedomics Business Overview
Table 96. BioMedomics Product
Table 97. Company Description and Business Overview
Table 98. BioMedomics COVID-19 In-Vitro Diagnostics Product
Table 99. BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 100. BioMedomics Recent Development
Table 101. BD Company Details
Table 102. BD Business Overview
Table 103. BD Product
Table 104. Company Description and Business Overview
Table 105. BD COVID-19 In-Vitro Diagnostics Product
Table 106. BD Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 107. BD Recent Development
Table 108. Henry Schein Company Details
Table 109. Henry Schein Business Overview
Table 110. Henry Schein Product
Table 111. Company Description and Business Overview
Table 112. Henry Schein COVID-19 In-Vitro Diagnostics Product
Table 113. Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 114. Henry Schein Recent Development
Table 115. Safecare Bio-Tech Company Details
Table 116. Safecare Bio-Tech Business Overview
Table 117. Safecare Bio-Tech Product
Table 118. Company Description and Business Overview
Table 119. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product
Table 120. Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 121. Safecare Bio-Tech Recent Development
Table 122. Mayo Clinic Laboratories Business Overview
Table 123. Mayo Clinic Laboratories Product
Table 124. Mayo Clinic Laboratories Company Details
Table 125. Company Description and Business Overview
Table 126. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product
Table 127. Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 128. Mayo Clinic Laboratories Recent Development
Table 129. Chembio Diagnostics Company Details
Table 130. Chembio Diagnostics Business Overview
Table 131. Chembio Diagnostics Product
Table 132. Company Description and Business Overview
Table 133. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 134. Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 135. Chembio Diagnostics Recent Development
Table 136. Mount Sinai Laboratory Company Details
Table 137. Mount Sinai Laboratory Business Overview
Table 138. Mount Sinai Laboratory Product
Table 139. Company Description and Business Overview
Table 140. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product
Table 141. Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 142. Mount Sinai Laboratory Recent Development
Table 143. Ortho Clinical Diagnostics Company Details
Table 144. Ortho Clinical Diagnostics Business Overview
Table 145. Ortho Clinical Diagnostics Product
Table 146. Company Description and Business Overview
Table 147. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 148. Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 149. Ortho Clinical Diagnostics Recent Development
Table 150. Zhejiang Orient Gene Biotech Company Details
Table 151. Zhejiang Orient Gene Biotech Business Overview
Table 152. Zhejiang Orient Gene Biotech Product
Table 153. Company Description and Business Overview
Table 154. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product
Table 155. Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 156. Zhejiang Orient Gene Biotech Recent Development
Table 157. Innovita Biological Technology Company Details
Table 158. Innovita Biological Technology Business Overview
Table 159. Innovita Biological Technology Product
Table 160. Company Description and Business Overview
Table 161. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product
Table 162. Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 163. Innovita Biological Technology Recent Development
Table 164. Guangzhou Wondfo Biotech Company Details
Table 165. Guangzhou Wondfo Biotech Business Overview
Table 166. Guangzhou Wondfo Biotech Product
Table 167. Company Description and Business Overview
Table 168. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product
Table 169. Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 170. Guangzhou Wondfo Biotech Recent Development
Table 171. Guangdong Hecin-Scientific Company Details
Table 172. Guangdong Hecin-Scientific Business Overview
Table 173. Guangdong Hecin-Scientific Product
Table 174. Company Description and Business Overview
Table 175. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product
Table 176. Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 177. Guangdong Hecin-Scientific Recent Development
Table 178. Dynamiker Biotechnology (Tianjin) Company Details
Table 179. Dynamiker Biotechnology (Tianjin) Business Overview
Table 180. Dynamiker Biotechnology (Tianjin) Product
Table 181. Company Description and Business Overview
Table 182. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product
Table 183. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 184. Dynamiker Biotechnology (Tianjin) Recent Development
Table 185. ADVAITE Company Details
Table 186. ADVAITE Business Overview
Table 187. ADVAITE Product
Table 188. Company Description and Business Overview
Table 189. ADVAITE COVID-19 In-Vitro Diagnostics Product
Table 190. ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business 2019 and 2020 (Million US$)
Table 191. ADVAITE Recent Development
Table 192. Company Description and Business Overview
Table 193. Company Description and Business Overview
Table 194. Company Description and Business Overview
Table 195. Company Description and Business Overview
Table 196. Company Description and Business Overview
Table 197. Company Description and Business Overview
Table 198. Company Description and Business Overview
Table 199. Company Description and Business Overview
Table 200. Company Description and Business Overview
Table 201. Company Description and Business Overview
Table 202. Company Description and Business Overview
Table 203. Company Description and Business Overview
Table 204. Company Description and Business Overview
Table 205. Company Description and Business Overview
Table 206. Company Description and Business Overview
Table 207. Company Description and Business Overview
Table 208. Company Description and Business Overview
Table 209. Company Description and Business Overview
Table 210. Company Description and Business Overview
Table 211. Company Description and Business Overview
Table 212. Company Description and Business Overview
Table 213. Company Description and Business Overview
Table 214. Company Description and Business Overview
Table 215. Key Drivers: Impact Analysis (2021-2026)
Table 216. Key Opportunities
Table 217. Key Challenges
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global COVID-19 In-Vitro Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Rapid Diagnostic Test (RDT) Features
Figure 3. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 4. Neutralization Assay Features
Figure 5. Global COVID-19 In-Vitro Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Home Case Studies
Figure 7. Hospital Case Studies
Figure 8. Clinical Case Studies
Figure 9. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 10. Global COVID-19 In-Vitro Diagnostics and Growth Rate (2019-2026) (Million US$)
Figure 11. Global COVID-19 In-Vitro Diagnostics Market Share by Regions (2019-2026)
Figure 12. Global COVID-19 In-Vitro Diagnostics Market Share by Players in 2019
Figure 13. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2019-2026)
Figure 14. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2019-2026)
Figure 15. North America COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. Europe COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. China COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Japan COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Southeast Asia COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. India COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Central & South America COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed